Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafei Chai

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Cell & Bioscience|December 14, 2020
Post-translational modifications of EZH2 in cancerZhongwei Li, Minle Li, Diandian Wang, et al.
Iscience|March 7, 2023
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8<sup>+</sup>T cell immune response and elicits potential therapeutic effect in hepatocellular carcinomaXiaoqing Shi, Jiage Ding, Yanyan Zheng, et al.
Cancer Biology & Medicine|January 3, 2024
Cancer-educated neutrophils promote lung cancer progression <i>via</i> PARP-1-ALOX5-mediated MMP-9 expressionLulu Han, Yuxin Chen, Nan Huang, et al.
Journal of Cellular and Molecular Medicine|August 31, 2018
H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinomaDafei Chai, Nianli Liu, Huizhong Li, et al.
Blood|November 22, 2024
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutationWei Li, Ruirui Wang, Junhao Wang, et al.
Journal of Hematology & Oncology|June 17, 2024
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutantDafei Chai, Junhao Wang, Chunmei Fan, et al.
Cancer Science|January 3, 2022
Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune functionHui Tian, Gang Wang, Qiping Wang, et al.
Journal of Cellular and Molecular Medicine|November 6, 2020
gB co-immunization with GP96 enhances pulmonary-resident CD8 T cells and exerts a long-term defence against MCMV pneumonitisBingnan Guo, Peifeng Xu, Dafei Chai, et al.
International Immunopharmacology|February 25, 2019
Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancerJie Yang, Jie Yang, Yanhong Wei, et al.
International Journal of Biological Macromolecules|December 8, 2024
Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinomaBowen Lu, Leizi Chai, Zichun Zhang, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Cell & Bioscience|December 14, 2020
Post-translational modifications of EZH2 in cancerZhongwei Li, Minle Li, Diandian Wang, et al.
Iscience|March 7, 2023
HMGB1/GPC3 dual targeting vaccine induces dendritic cells-mediated CD8<sup>+</sup>T cell immune response and elicits potential therapeutic effect in hepatocellular carcinomaXiaoqing Shi, Jiage Ding, Yanyan Zheng, et al.
Cancer Biology & Medicine|January 3, 2024
Cancer-educated neutrophils promote lung cancer progression <i>via</i> PARP-1-ALOX5-mediated MMP-9 expressionLulu Han, Yuxin Chen, Nan Huang, et al.
Journal of Cellular and Molecular Medicine|August 31, 2018
H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinomaDafei Chai, Nianli Liu, Huizhong Li, et al.
Blood|November 22, 2024
Lasalocid A selectively induces the degradation of MYD88 in lymphomas harboring the MYD88 L265P mutationWei Li, Ruirui Wang, Junhao Wang, et al.
Journal of Hematology & Oncology|June 17, 2024
Remodeling of anti-tumor immunity with antibodies targeting a p53 mutantDafei Chai, Junhao Wang, Chunmei Fan, et al.
Cancer Science|January 3, 2022
Complement C1q binding protein regulates T cells' mitochondrial fitness to affect their survival, proliferation, and anti-tumor immune functionHui Tian, Gang Wang, Qiping Wang, et al.
Journal of Cellular and Molecular Medicine|November 6, 2020
gB co-immunization with GP96 enhances pulmonary-resident CD8 T cells and exerts a long-term defence against MCMV pneumonitisBingnan Guo, Peifeng Xu, Dafei Chai, et al.
International Immunopharmacology|February 25, 2019
Modification of IL-24 by tumor penetrating peptide iRGD enhanced its antitumor efficacy against non-small cell lung cancerJie Yang, Jie Yang, Yanhong Wei, et al.
International Journal of Biological Macromolecules|December 8, 2024
Co-immunization with IFI35 enhances the therapeutic effect of an adenovirus vaccine against renal carcinomaBowen Lu, Leizi Chai, Zichun Zhang, et al.
Pageof 6